Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2017	Oct. 02, 2016
Cash flows from operating activities:
Net income (loss)	$ 83,772	$ 86,584
Adjustments to reconcile net income (loss) to net cash flow provided by (used in) operating activities:
Loss (income) from discontinued operations, net of tax	518	608
Loss (gain) on disposal of subsidiaries	212	(6,575)
Depreciation	43,475	43,378
Amortization	17,782	19,199
Share based compensation expense	8,694	11,922
Deferred income taxes	8,359	7,924
Unrealized foreign exchange loss (gain)	1,083	789
Share of loss (income) from equity investees, net of tax	(1,293)	(1,413)
Dividend from equity investee	0	1,733
Pension and post-retirement expense (funding), net	(5,743)	(5,632)
Non-cash accruals and interest	1,161	2,212
Loss (gain) on sale of property, plant and equipment	1,529	1,090
Accounts receivable	(39,532)	(51,285)
Inventories	(18,399)	(33,218)
Prepaid expenses	(1,745)	1,145
Accounts payable and accrued expenses	2,993	13,665
Other assets and liabilities	(4,761)	(274)
Net cash flow provided by (used in) operating activities	98,105	91,852
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	962	1,280
Additions to property, plant and equipment	(52,340)	(57,915)
Cash used in acquisitions, net of cash acquired	0	(599)
Cash proceeds from sale of subsidiaries, net of cash disposed	0	15,103
Restricted cash	301	449
Other investing activities	(2,793)	(1,761)
Net cash flow provided by (used in) investing activities	(53,870)	(43,443)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	155,246	390
Repayments of long-term debt	(332)	(881)
Tax witholding on share based awards	(6,167)	(4,057)
Distributions to non-controlling interests	(2,955)	(2,660)
Proceeds from exercise of common stock warrants	0	10,487
Repurchases of common shares	(109,866)	(90,180)
Net cash flow provided by (used in) financing activities	35,926	(86,901)
Net foreign currency translation adjustment on cash	(844)	(2,271)
Increase (decrease) in cash and cash equivalents	79,317	(40,763)
Cash and cash equivalents, beginning of period	71,714	89,187
Cash and cash equivalents, at end of period	$ 151,031	$ 48,424